Faculty of Biomedical and Life Sciences, Limburg Clinical Research Center/Mobile Health Unit, Hasselt University, Diepenbeek, Belgium.
Department of Future Health, Ziekenhuis Oost Limburg, Genk, Belgium.
J Appl Physiol (1985). 2023 Dec 1;135(6):1330-1338. doi: 10.1152/japplphysiol.00600.2022. Epub 2023 Sep 28.
In contrast to whole body bioimpedance, which estimates fluid status at a single point in time, thoracic bioimpedance applied by a wearable device could enable continuous measurements. However, clinical experience with thoracic bioimpedance in patients on dialysis is limited. To test the reproducibility of whole body and thoracic bioimpedance measurements and to compare their relationship with hemodynamic changes during hemodialysis, these parameters were measured pre- and end-dialysis in 54 patients during two sessions. The resistance from both bioimpedance techniques was moderately reproducible between two dialysis sessions (intraclass correlations of pre- to end-dialysis whole body and thoracic resistance between and were 0.711 [0.58-0.8] and 0.723 [0.6-0.81], respectively). There was a very high to high correlation between changes in ultrafiltration volume and changes in whole body thoracic resistance. Changes in systolic blood pressure negatively correlated to both bioimpedance techniques. Although the relationship between changes in ultrafiltration volume and changes in resistance was stronger for whole body bioimpedance, the relationship with changes in blood pressure was at least comparable for thoracic measurements. These results suggest that thoracic bioimpedance, measured by a wearable device, may serve as an interesting alternative to whole body measurements for continuous hemodynamic monitoring during hemodialysis. We examined the role of whole body and thoracic bioimpedance in hemodynamic changes during hemodialysis. Whole body and thoracic bioimpedance signals were strongly related to ultrafiltration volume and moderately, negatively, to changes in blood pressure. This work supports the further development of a wearable device measuring thoracic bioimpedance longitudinally in patients on hemodialysis. As such, it may serve as an innovative tool for continuous hemodynamic monitoring during hemodialysis in hospital or in a home-based setting.
与估计单点时间内液体状态的全身生物阻抗相比,可穿戴设备应用的胸生物阻抗可以实现连续测量。然而,在透析患者中应用胸生物阻抗的临床经验有限。为了测试全身和胸生物阻抗测量的可重复性,并比较它们与血液透析过程中血液动力学变化的关系,在两次透析期间对 54 例患者的这些参数进行了两次透析前和透析后的测量。两次透析期间,两种生物阻抗技术的电阻均具有中度可重复性(透析前至透析后全身和胸电阻的组内相关系数分别为 0.711 [0.58-0.8]和 0.723 [0.6-0.81])。超滤量的变化与全身胸电阻的变化之间存在高度至高度相关。收缩压的变化与两种生物阻抗技术均呈负相关。虽然全身生物阻抗的超滤量变化与电阻变化之间的关系更强,但与血压变化的关系至少与胸部测量相当。这些结果表明,由可穿戴设备测量的胸生物阻抗可能是血液透析期间连续血液动力学监测的全身测量的有趣替代方法。我们研究了全身和胸生物阻抗在血液透析过程中血液动力学变化中的作用。全身和胸生物阻抗信号与超滤量密切相关,与血压变化呈中度负相关。这项工作支持进一步开发可穿戴设备,对血液透析患者进行胸生物阻抗的纵向测量。因此,它可以作为血液透析过程中在医院或家庭环境中进行连续血液动力学监测的创新工具。